IMPACT OF METABOLIC SYNDROME ON LIVER DISEASE PROGRESSION AND TREATMENT RESPONSE

Main Article Content

Dr. Shivaji V. Raje, Dr. Ganesh Thorat, Dr. Mrs.Kapale R.J.

Abstract

Introduction: MetS, comprising obesity, insulin resistance, dyslipidemia, and hypertension, significantly impacts liver disease progression. Our study aims to explore how MetS influences NAFLD, NASH, and ALD, considering prevalence, severity, treatment response, and clinical implications.
Objective: This study investigates the impact of MetS on liver diseases, examining prevalence, severity, treatment response, and clinical implications, aiming to inform tailored management strategies for affected individuals.
Results: MetS components are prevalent in liver disease cohorts, correlating with more severe liver histology, increased risk of adverse outcomes, and treatment challenges. Integrated management approaches are crucial for optimizing outcomes in this population.
Conclusion: Understanding the intricate relationship between MetS and liver diseases is crucial for developing personalized management approaches. Further research is needed to elucidate underlying mechanisms and develop targeted interventions for improved clinical outcomes.

Article Details

How to Cite
Dr. Mrs.Kapale R.J., D. S. V. R. D. G. T. (2024). IMPACT OF METABOLIC SYNDROME ON LIVER DISEASE PROGRESSION AND TREATMENT RESPONSE. Obstetrics and Gynaecology Forum, 34(3s), 618–625. Retrieved from http://obstetricsandgynaecologyforum.com/index.php/ogf/article/view/324
Section
Articles

Similar Articles

1 2 3 4 5 6 7 8 > >> 

You may also start an advanced similarity search for this article.